Deferasirox 45963-0455-30

Package NDC

45963-0455-30

Manufacturer: Actavis Pharma, Inc.
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: March 22, 2019
Application: ANDA203560

Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Deferasirox	250 mg/1

Drug Class

Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]

Selected Package

45963-0455-30Selected

30 TABLET, FOR SUSPENSION in 1 BOTTLE (45963-455-30)